Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients

Cytokine

Volumn 61, Issue 1, 2013, Pages 218-222

  Vaccarino, Loredana ^a   Vitale, Silvana ^a   Caruso, Marco ^a   Palmeri, Marisa ^a   Scola, Letizia ^a   Bova, Manuela ^a   Caruso, Calogero ^a   Massenti, Maria Fatima ^a   Vitale, Francesco ^a   Novo, Salvatore ^a   Lio, Domenico ^a   Forte, Giusi Irma ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acute myocardial infarction; Haematochemical parameters; Pro thrombin; SNPs; Tumor necrosis factor

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; FIBRINOGEN; PROTHROMBIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTHROMBIN GENE; SICILIAN; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; FIBRINOGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; TROPONIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84869873078     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.021     Document Type: Article

References (45)

1. Doughty M., Mehta R., Bruckman D., et al. Acute myocardial infarction in the young. The University of Michigan experience. Am Heart J 2002, 143:56-62.
2. Zimmerman F.H., Cameron A., Fisher L.D., Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995, 26:654-661.
3. Williams M.J., Restieaux N.J., Low C.J.S. Myocardial infarction in young people with normal coronary arteries. Heart 1998, 79:191-194.
4. Zdravkovic S., Wienke A., Pedersen N.L., de Faire U. Genetic susceptibility of myocardial infarction. Twin Res Hum Genet 2007, 10:848-852.
5. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
6. Ozaki K., Sato H., Iida A., et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 2006, 38:921-925.
7. Hubacek J.A., Rothe G., Pit'ha J., et al. C(-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999, 99:3218-3220.
8. Georges J.L., Loukaci V., Poirier O., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001, 79:300-305.
9. Um J.Y., Moon K.S., Lee K.M., et al. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res 2003, 115:50-54.
10. Bernard V., Pillois X., Dubus I., et al. The -308G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med 2003, 41:511-516.
11. Gretarsdottir S., Thorleifsson G., Reynisdottir S.T., et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003, 35:131-138.
12. Banerjee I., Gupta V., Ahmed T., Faizaan M., Agarwal P., Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 2008, 75(1):158-165.
13. Lio D., Candore G., Crivello A., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004, 41:790-794.
14. Licastro F., Chiapelli M., Caldarera C.M., Caruso C., Lio D., Corder E H. Acute myocardial infarction and proinflammatory. Gene Variants Ann NY Acad Sci 2007, 1119:227-242.
15. Lio D., Candore G., Colombo A., et al. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 2001, 62:705-713.
16. Scola L., Crivello A., Marino V., et al. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 2003, 124:569-572.
17. Giacconi R., Caruso C., Malavolta M., et al. Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res Rev 2008, 7:306-318.
18. Forte G.I., Scola L., Misiano G., et al. Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever. Clin Vaccine Immunol 2009, 16:811-815.
19. Wilson A.G. Typing of tumor necrosis factor alleles. Methods Mol Biol 2003, 210:297-304.
20. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
21. Allen R.D. Polymorphism of the human TNF-alpha promoter-random variation or functional diversity. Mol Immunol 1999, 36:1017-1027.
22. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001, 88:10-15.
23. Zhang H.F., Xie S.L., Wang J.F., Chen Y.X., Wang Y., Huang T.C. Tumor necrosis factor-alpha G -308A gene polymorphism and coronary heart disease susceptibility: an updated meta-analysis. Thromb Res 2011, 127:400-405.
24. Mannucci P.M., Asselta R., Duga S., et al. The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease. J Thromb Haemost 2010, 8:2116-2121.
25. Ye Z., Liu E.H., Higgins J.P., et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006, 367:651-658.
26. Burzotta F., Leone A.M., Paciaroni K., et al. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome. Haematologica 2004, 89:1134-1138.
27. Incalcaterra E., Hoffmann E., Averna M.R., Caimi G. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol 2004, 52:287-312.
28. Burzotta F., Paciaroni K., De Stefano V., et al. G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12,034 subjects. Heart 2004, 90:82-86.
29. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3'-Untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
30. Alhenc-Gelas M., Arnaud E., Nicaud V., et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999, 81:506-510.
31. Rosendaal F.R., Doggen C.J.M., Zivelin A., et al. Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 1998, 79:706-708.
32. Arruda V.D., Bizzacchi J.M., Goncalves M.S., et al. Prevalence of the prothrombin gene variant (nt 20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997, 78:1430-1433.
33. Peetz D., Schweigert R., Jachmann N., Post F., Schinzel H., Lackner K.J. Method comparison of cardiac marker assays on PATHFAST, Stratus CS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader. Clin Lab 2006, 52:605-614.
34. Lippi G., Guidi G.C. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med 2007, 45:720-727.
35. Galbraith G.M., Pandey J.P. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 1995, 96:433-436.
36. Vaccarino L., Forte G.I., Palmeri M., et al. Role of prothrombotic polymorphisms in successful or unsuccessful aging. Biogerontology 2011, 12:445-450.
37. Miller G.J., Bauer K.A., Barzegar S., et al. Increased activation of the hemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996, 75:767-771.
38. Franco R.F., Trip M.D., ten Cate H., et al. The 20210GA mutation in the 3' untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 1999, 104:50-54.
39. Watzke H.H., Schüttrumpf J., Graf S., et al. Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res 1997, 87:521-526.
40. Ridker P.M., Hennekens C.H., Miletich J.P. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999, 99:999-1004.
41. Cavallini C., Savonitto S., Violini R., et al. Italian 'Atherosclerosis, Thorombosis, and Vascular Biology' and 'Society for Invasive Cardiology-GISE' Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 2005, 26:1494-1498.
42. Danesh J., Collins R., Peto R., Lowe G.D.O. Haematocrit, viscosity, erythrocyte sedimentation rate: metaanalyses of prospective studies of coronary heart disease. Eur Heart J 2000, 21:515-520.
43. Lowe G.D.O. Fibrinogen and cardiovascular disease: historical introduction. Eur Heart J 1995, 16(Suppl. A):2-5.
44. Hashmi J.A., Afroze N., Syed S.A. Fibrinogen levels in patients suffering from acute myocardial infarction. J Atheroscler Res 1969, 10:277-281.
45. Tatli E., Ozcelik F., Aktoz M. Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction. Cardiol J 2009, 16:317-320.